Background and Format: Launched in 1989, Pharmaceutical Technology Europe (PTE) is published by Advanstar Communications monthly and is aimed at professionals involved in pharmaceutical and biopharmaceutical development, manufacturing and quality control. Covers news, peer-reviewed research, regulatory watch, outsourcing outlook, API synthesis and manufacturing, troubleshooting, global report, viewpoints and statistics.  It also has a sister publication Pharmaceutical Technology. The media pack is available from: www.pharmtech.com/node/323540/done?sid=20919 Circulation: (Source: Publisher)

Reaches manufacturers of pharmaceutical and clinical diagnostic products, producers of bulk and raw materials and manufacturers of medical devices and instrumentation. Content covers manufacturing, machinery and equipment, excipients, chemicals and raw materials, solid dosage forms, parenterals, contract manufacturing and services as well as process control, computer systems and validation, filtration, packaging, biotechnology trends and drug delivery systems.

Background and Format: Pharmaceutical-technology.com website focuses specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. The website seeks to bring the latest in industry projects and updates, along with the news, views and trends that leading professionals - from senior executives to manufacturing managers and heads of procurement - require to stay on top of their field. With an international scope, the team examine all pharmaceutical markets closely, from biotechnology to therapeutics, vaccines and more. Pharmaceutical-technology.com aims to combine this with one of the most comprehensive and detailed listings of pharmaceutical equipment suppliers, products and services, free white paper downloads and company press releases, you can see why pharmaceutical-technology.com is the key point of reference for the pharma industry. Furthermore, their careers portal Industry Appointments (industryappointments.com) puts recruiters and job candidates in touch with each other.                 There's a regular e-newsletter which users can sign up to get the latest updates on the pharmaceutical industry. Audience and Readership: It is aimed at pharmaceutical professionals working with technology, be it development, engineering or IT or production as well as manufacturing managers and heads of procurement Monthly Unique Users: Source: Publisher Ad Rates: For further information about advertising, email magsales@nridigital.com or complete the online form here

Background and Format: They monitor 115 countries and aim to keep readers up-to-date with key developments including market forecast trends, monthly and annual trade performance, healthcare reforms, government investment programmes, regulatory developments, production changes, leading national and multinational manufacturers and competitive strategies. Audience and Readership: Decision makers from multinational corporations, banks and insurance companies, medical companies, consultancies and sector specialists and government departments Frequency: It is on a 13-month rolling basis Circulation: No figure available Other Information: It is best to direct enquiries to enquiry@bmiresearch.com or contact via the form here Alerts: Gorkana alert: Thursday 27th September 2007 Espicom Business Intelligence the healthcare publishers, have restructured their communications network. Principal staff contacts are as follows: Andrew Crofts, Primary Editor covering healthcare markets (world pharmaceutical markets and medistat) - +44 (0)1243 756 003 and andrew_crofts@espicom.com Jeremy Webber, Primary Editor covering pharmaceutical companies analysis - +44 (0)1243 756 024 and jeremy_webber@espicom.com Fiona Cowie, Primary Editor covering pharmaceutical news - +44 (0)1243 756 013 and fiona_cowie@espicom.com Lawrence Miller, Primary Editor covering medical device news - +44 (0)1243 756 031 and lawrence_miller@espicom.com Chris Swann, Press contact / Market briefings - +44 (0)1243 756 054 and chris_swann@espicom.com Julie Ash, Business development - +44 (0)1243 756 027 and julie_ash@espicom.com Publications include: Anti-Infective Drug News, Autoimmune Drug Focus, Cancer Drug News, Cardiovascular Device Business, Cardiovascular Drug News, CNS Drug News, Drug Delivery Insight, Medical Imaging Business, Medical Industry Week, Neuro Drug Focus, Orthopaedics Business, Pharma Agreement News, Pharma Company Insight, The Diabetes Report, World Generic Markets, Generic Companies Analysis, Generic Markets Analysis, Medical Device Companies Analysis, Medistat - World Medical Markets Analysis and World Pharmaceutical Markets. All press releases should be sent to healthcare@espicom.com and general enquiries via +44 (0)1243 533 322

Written for pharmacists and others dispensing drugs. Provides analysis of new drugs and research, as well as professional opportunities. Includes advice on establishing and strengthening relationships with both physicians and patients. Covers current drug therapy as it pertains to pharmacists. The Letter gives pharmacists very short concise updates and advice. The Detail-Documents provide in-depth coverage answering many specific questions related to each topic.

Impact factor: 2.710 Circulation: The publisher does not disclose the circulation Frequency: 16 issues per year Aims of the journal: Pharmacogenics is a monthly peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Content: The journal focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community, including: The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies Emerging technologies for accessing and exploiting genomic information Reviews of genotyping and clinical data in particular therapeutic areas Development of novel diagnostic products and strategies Editorial Contacts: An online editorial board can be viewed here Manuscript Submission: Unsolicited manuscripts are accepted for publication; contact the Commissioning Editor with a brief proposal and article outline. All review articles published in the journals are subject to rigorous peer-review by independent experts in the field. Author guidelines can be viewed at here. Online manuscript submission can be found here Ad Rates: Further information on ad rates can be found here.

Dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications. Covers the identification of novel genomic targets for drug development, the clinical applications of genomic science, potential benefits of pharmacogenomics, effect of genetic variability on drug toxicity and efficacy, pharmacokinetic variation and drug toxicity, and pharmacodynamic variation and drug efficacy. Integrates new developments in genomics and proteomics to clinical medicine, pharmacology, and therapeutics. Consists of original research, reviews, debates and controversies.

Written for pharmaceutical chemists, physiologists, virologists and microbiologists. Covers important topics in pharmacology. The outlet can be reached at P&T@kumc.edu.

Edited for professionals responsible for the selection and proper use of drugs in hospitals and healthcare facilities. Provides comprehensive and authoritative evaluations of new drugs introduced in the United States as they are released on the market. Articles evaluate new uses for older drugs, review the drug treatment of selected diseases, reassess older drugs and examine controversial topics in drug therapy.

Pharmacy Benefit Management Blog covers Pharmacy Benefits. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. This blog offers RSS (Really Simple Syndication).